Joint UK societies’ 2014 consensus statement on renal denervation for resistant hypertension
In response to the announcement of the Symplicity HTN-3 study results earlier this year, the Joint UK Societies’ issued an initial response suggesting a temporary moratorium on the use of renal denervation in the UK until further advice (RA eNews February 2014). The Joint UK Societies’ consensus statement on renal denervation for resistant hypertension is now published on line (link below). Essentially it says that although the Joint UK Societies’ group recognises that there were a number of flaws in the design and conduct of the Symplicity HTN-3 study, it does not recommend the use of renal denervation for treatment of resistant hypertension in routine clinical practice. However, it remains committed to supporting research activity in this field with a view to ensuring better design and conduct of future randomised studies. This article is also an excellent review of the current state of knowledge about renal denervation.
Indranil Dasgupta on behalf of the Joint UK Societies on renal denervation.